Elkayam E, Gervais F, Wu H, A Crackower M, Lieberman J
Nat Rev Immunol. 2025; .
PMID: 40044809
DOI: 10.1038/s41577-025-01142-9.
Wu J, Ding C, Zhang C, Xu Z, Deng Z, Wei H
Nat Commun. 2025; 16(1):2184.
PMID: 40038267
PMC: 11880502.
DOI: 10.1038/s41467-025-57511-4.
Wang Y, Li R, Ye Q, Fei D, Zhang X, Huang J
Int J Oral Sci. 2025; 17(1):14.
PMID: 40000642
PMC: 11861291.
DOI: 10.1038/s41368-024-00331-x.
Li Y, Guo B
Mol Biomed. 2025; 6(1):11.
PMID: 39994107
PMC: 11850691.
DOI: 10.1186/s43556-025-00249-8.
Liu L, Han F, Du N, Liu Y, Duan A, Kang S
Front Immunol. 2025; 15:1507083.
PMID: 39872538
PMC: 11769811.
DOI: 10.3389/fimmu.2024.1507083.
Decursinol angelate relieves inflammatory bowel disease by inhibiting the ROS/TXNIP/NLRP3 pathway and pyroptosis.
Wang Y, Wang J, Chen Y, Li X, Jiang Z
Front Pharmacol. 2025; 15():1520040.
PMID: 39840084
PMC: 11747577.
DOI: 10.3389/fphar.2024.1520040.
PTPN23-dependent ESCRT machinery functions as a cell death checkpoint.
Song D, Cen Y, Qian Z, Wu X, Rivera K, Wee T
Nat Commun. 2024; 15(1):10364.
PMID: 39609437
PMC: 11604704.
DOI: 10.1038/s41467-024-54749-2.
Ferroptosis: mechanisms and therapeutic targets.
Zhou Q, Meng Y, Le J, Sun Y, Dian Y, Yao L
MedComm (2020). 2024; 5(12):e70010.
PMID: 39568772
PMC: 11577302.
DOI: 10.1002/mco2.70010.
The role of pyroptosis in cancer: key components and therapeutic potential.
Liu Z, Xu S, Chen L, Gong J, Wang M
Cell Commun Signal. 2024; 22(1):548.
PMID: 39548573
PMC: 11566483.
DOI: 10.1186/s12964-024-01932-z.
Pyroptosis: Induction and inhibition strategies for immunotherapy of diseases.
Wu J, Wang H, Gao P, Ouyang S
Acta Pharm Sin B. 2024; 14(10):4195-4227.
PMID: 39525577
PMC: 11544194.
DOI: 10.1016/j.apsb.2024.06.026.
Improving lung allograft function in the early post-operative period through the inhibition of pyroptosis.
Gouchoe D, Zhang Z, Kim J, Lee Y, Whitson B, Zhu H
Med Rev (2021). 2024; 4(5):384-394.
PMID: 39444796
PMC: 11495470.
DOI: 10.1515/mr-2023-0066.
Inflammasome-mediated pyroptosis in defense against pathogenic bacteria.
Oh C, Spears T, Aachoui Y
Immunol Rev. 2024; 329(1):e13408.
PMID: 39404258
PMC: 11741929.
DOI: 10.1111/imr.13408.
Cell death: Revisiting the roads to ruin.
Green D
Dev Cell. 2024; 59(19):2523-2531.
PMID: 39378838
PMC: 11469552.
DOI: 10.1016/j.devcel.2024.08.008.
Antagonistic nanobodies implicate mechanism of GSDMD pore formation and potential therapeutic application.
Schiffelers L, Tesfamariam Y, Jenster L, Diehl S, Binder S, Normann S
Nat Commun. 2024; 15(1):8266.
PMID: 39327452
PMC: 11427689.
DOI: 10.1038/s41467-024-52110-1.
Embryo-Derived Cathepsin B Promotes Implantation and Decidualization by Activating Pyroptosis.
Li M, Wu Y, Tang H, Wang Y, Li B, He Y
Adv Sci (Weinh). 2024; 11(43):e2402299.
PMID: 39316370
PMC: 11578360.
DOI: 10.1002/advs.202402299.
Endoplasmic reticulum membrane remodeling by targeting reticulon-4 induces pyroptosis to facilitate antitumor immune.
Zhao M, Ren T, Wang J, Yao L, Liu T, Zhang J
Protein Cell. 2024; 16(2):121-135.
PMID: 39252612
PMC: 11786723.
DOI: 10.1093/procel/pwae049.
Gasdermins as evolutionarily conserved executors of inflammation and cell death.
Chen K, Broz P
Nat Cell Biol. 2024; 26(9):1394-1406.
PMID: 39187689
DOI: 10.1038/s41556-024-01474-z.
Gasdermin D cysteine residues synergistically control its palmitoylation-mediated membrane targeting and assembly.
Margheritis E, Kappelhoff S, Danial J, Gehle N, Kohl W, Kurre R
EMBO J. 2024; 43(19):4274-4297.
PMID: 39143238
PMC: 11445239.
DOI: 10.1038/s44318-024-00190-6.
Multiple sclerosis: the NLRP3 inflammasome, gasdermin D, and therapeutics.
Brint A, Greene S, Fennig-Victor A, Wang S
Ann Transl Med. 2024; 12(4):62.
PMID: 39118955
PMC: 11304424.
DOI: 10.21037/atm-23-1960.
Identification of Molecular Correlations of GSDMD with Pyroptosis inAlzheimer's Disease.
Song T, Chen Y, Li C, Yao Y, Ma S, Shang Y
Comb Chem High Throughput Screen. 2024; 27(14):2125-2139.
PMID: 39099451
DOI: 10.2174/0113862073285497240226061936.